Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2026-01-01 @ 7:51 AM
Study NCT ID:
NCT07051369
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-04
First Post:
2025-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound
Sponsor:
Superior University
Organization:
Study Overview
Official Title:
Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Portal hypertension is a common and serious complication of liver cirrhosis, often leading to life-threatening conditions such as variceal bleeding, ascites, and hepatic encephalopathy.
Detailed Description:
Early detection and management are crucial for improving patient outcomes. While invasive methods such as hepatic venous pressure gradient (HVPG) measurement are the gold standard for diagnosis, they are costly and not widely available. Ultrasound, particularly Doppler imaging, offers a non-invasive, cost- effective alternative for assessing portal hypertension.This study aims to determine the frequency of portal hypertension among patients with cirrhotic liver using ultrasound.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: